According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

or damage to the stomach lining from anti-inflammatory drugs such as ibuprofen were 76% more likely to develop Parkinson's disease. They say recognizing the role the gut may play in Parkinson's ...

A team from the Wistar Institute has demonstrated the role of Parkin—a protein implicated in Parkinson's disease—in the ...

A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson's disease, signaling a ...

Researchers have linked upper gastrointestinal tract damage to a higher risk for developing Parkinson’s disease.

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

announces the direct CNS anti-inflammatory effect of subcutaneously administered COYA 302 in a preclinical inflammatory associated mouse model of Parkinson’s Disease (PD). Coya’s Chief Business ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.

Two monoclonal antibody treatments to slow Alzheimer's disease ... Study finds genetic link between Parkinson's disease, ALS People with rare genetic variants linked to degenerative brain ...

But some 80 percent of people with Parkinson's disease have GI problems, such as acid reflux, irritable bowel syndrome, and constipation, which often emerge decades before motor difficulties do. This ...